Owens & Minor Q4 adjusted EPS $0.69, revenue $2.66B; full year operating cash flow $741M

ACCENDRA HEALTH INC/VA/

2023-FY EPS reported -$0.54 revenue$10,333,967,000

Q4 GAAP net income $17.8M vs loss of $58.0M; adjusted net income $53.6M vs $21.7M.
Full year adjusted EPS $1.36 vs $2.42; GAAP net loss per share $(0.54) vs $0.29.
Total debt reduced by $403M, net debt reduced by $577M; operating cash flow $741M.
Full year revenue $10.3B, up 4% from $9.96B; Q4 revenue $2.66B vs $2.55B.
Patient Direct segment outperformed; Products & Healthcare Services showed sequential improvement.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ACCENDRA HEALTH INC/VA/ reported the fourth quarter and year ended December 31, 2023 results: revenue $10.3 billion, net income Net loss per common share of $(0.54) and adjusted net income per common share of $1.36.

Period: the fourth quarter and year ended December 31, 2023
Revenue: $10.3 billion
Net income: Net loss per common share of $(0.54) and adjusted net income per common share of $1.36
Result: reported results

Exact text from the filing

& Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. Full Year 2023 Key Highlights: ● Consolidated revenue of $10.3 billion ● Delivered $741 million of operating cash flow ● Reduced total debt by $403 million and reduced net debt by $577 million ● Net loss per common share of $(0.54) and adjusted net

View on SEC.gov

201 earnings releases filed in the last 30 days. Browse all earnings releases →

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001558370-24-001321

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.